Arkolith/Insider Trading/RPHM/Form 4

Leonard Braden Michael

10% OwnerReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Sep 16, 2024
Net Buying
Open-Market Buys
$484K
Open-Market Sells
$0
Net Open-Market Flow
$484K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2024Buy(P)173K$1.37$237K3.3M
Sep 13, 2024Buy(P)150K$1.31$197K3.1M
Sep 12, 2024Buy(P)36K$1.40$51K3.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001373604-24-000090) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML